I was pleasantly surprised to discover that Schwab accepted two sell orders, one ",,,in the single dollar range (<$10)," as well as a sell order at $100. They would not accept the $200 sell price, so I may have to be at the computer to enter that, should I be able to do so.
But a squeeze could be extremely short-lived, lasting no more than minutes before the computers kick in. And it was reassuring to know that I might catch the spike with my "GTC+ext" sell order, even if I'm not at the computer during a price spike.
Also, I was glad to see the company make note of Twitter poster 'gloriacain's' post, at it may relate to the, "...ACTIV-5 study, which is expected to reveal early biomarker data."
The Paxlovid approval actually gave me reason to think that the ACTIV-5 ratios >1 in treating severe and critical patients may be viewed favorably, even if not statistically significant. This is especially true if the data shows sustained reductions in cytokine levels.